Abo Bibliothek: Guest
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen
Critical Reviews™ in Eukaryotic Gene Expression
Impact-faktor: 1.841 5-jähriger Impact-Faktor: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN Druckformat: 1045-4403
ISSN Online: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukarGeneExpr.v6.i2-3.50
pages 189-214

Utilization of Nuclear Matrix Proteins for Cancer Diagnosis

Susan K. Keesee
Matritech, Inc., 330 Nevada St., Newton, MA 02160
Joseph V. Briggman
Matritech, Inc., 330 Nevada St., Newton, MA 02160
Gregory Thill
Matritech, Inc., 330 Nevada St., Newton, MA 02160
Ying-Jye Wu
Matritech, Inc., 330 Nevada St., Newton, MA 02160

ABSTRAKT

Circulating tumor markers have been used increasingly in recent years as clinical tools for cancer diagnosis and management. This review presents a brief discussion of currently available tumor-associated antigens. Included is an overview of different functional classes of circulating markers and their clinical applications. The limitations of some traditional tumor markers presently in widespread use are discussed in the context of the properties exhibited by an ideal tumor marker. The nuclear matrix provides structural support for the nucleus and plays a dynamic role in the spatial organization of the genome and in the control of DNA replication and transcription. The recovery of increased amounts of specific nuclear matrix proteins in several different cancers has led to the further study of some of these proteins as a new class of tumor markers. Progress on the use of a nuclear matrix protein known as NuMA as a marker for bladder cancer is presented, including results of a recently completed multisite clinical trial. Additional studies on the potential utility of nuclear matrix proteins as markers for prostate cancer are also presented. Nuclear matrix proteins could provide for the development of assays with increased efficacy for the diagnosis and treatment of cancer.


Articles with similar content:

Architectural Genetic and Epigenetic Control of Regulatory Networks: Compartmentalizing Machinery for Transcription and chromatin remodeling in nuclear Microenvironments
Critical Reviews™ in Eukaryotic Gene Expression, Vol.20, 2010, issue 2
Sayyed Kaleem Zaidi, Janet L. Stein, Jane B. Lian, Martin Montecino, Jeffrey A. Nickerson, Andre J. van Wijnen, Gary S. Stein, Anthony N. Imbalzano
The Impacts of miRNAs in Glioblastoma Progression
Critical Reviews™ in Eukaryotic Gene Expression, Vol.26, 2016, issue 2
Rasime Kalkan, Emine İkbal Atli
MicroRNAs as New Diagnostic and Prognostic Biomarkers in Urological Tumors
Critical Reviews™ in Oncogenesis, Vol.18, 2013, issue 4
Klaus Jung, Annika Fendler
Interrelationships of Transcriptional Machinery with Nuclear Architecture
Critical Reviews™ in Eukaryotic Gene Expression, Vol.9, 1999, issue 3-4
Janet L. Stein, Jane B. Lian, Andre J. van Wijnen, Gary S. Stein
Genetic Alterations in Liver Carcinogenesis: Implications for New Preventive and Therapeutic Strategies
Critical Reviews™ in Oncogenesis, Vol.11, 2000, issue 1
Francesco Feo, Maria R. De Miglio, Rosa M. Pascale, Maria M. Simile, Diego Calvisi, Maria R. Muroni